A metastatic bladder cancer diagnosis changes everything — not just your treatment plan, but also your daily life. In this series, a woman talks candidly with an oncology nurse about how to navigate ...

Hundreds of people with advanced bladder cancer across the UK can now receive three rather than six chemotherapy cycles following research by Queen Mary University of London which has led to a change ...

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending durvalumab (Imfinzi, AstraZeneca), given with gemcitabine and cisplatin before surgery and ...

For most people with bladder cancer, the first red flag is literally red: blood in the urine. But for people with color blindness, that warning sign may be easy to miss — and missing it could prove ...

In a population-based cohort of patients newly diagnosed with bladder cancer, post-diagnostic hyperglycaemia was associated with a higher risk for bladder cancer-specific and overall mortality than ...

Armed with new three-year data demonstrating the benefits of Anktiva in a specific patient subset, ImmunityBio is proving its bladder cancer med is still one to watch as it competes with heavy hitters ...

Tackling a common childhood virus could open the door to preventing bladder cancer, according to new research. The study, published in Science Advances by Dr. Simon Baker and colleagues at the ...

Squamous cell carcinoma of the bladder is rare, accounting for 2% to 5% of bladder cancers in the U.S., and is linked to chronic bladder irritation. Diagnosis involves cystoscopy, biopsy, and imaging ...

The FDA has approved Pfizer and Astellas’ Padcev (enfortumab vedotin-ejfv) plus Merck’s Keytruda (pembrolizumab) as a perioperative treatment for adults with muscle-invasive bladder cancer who are ...

Recurrences of low-, intermediate-, or high-/very high-risk tumors were again low, intermediate, or high risk in 74%, 62%, and 44% of cases, respectively. Recurrent non-muscle invasive bladder cancer ...

An experimental treatment method has shown promise in fighting a hard-to-treat form of bladder cancer known as BCG-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC). BCG (Bacillus ...